Introducing Seattle Genetics (NASDAQ:SGEN), The Stock That Zoomed 272% In The Last Five Years
NASDAQ:SGEN) shareholders would be well aware of this, since the stock is up 272% in five years. Then again, the 9.1% share price decline hasn’t been so fun for shareholders.” data-reactid=”28″>When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%. Long term Seattle Genetics, Inc. (NASDAQ:SGEN) shareholders would be well aware of this, since the stock is up 272% in five years. Then again, the 9.1% share price decline hasn’t been so fun for shareholders.
See our latest analysis for Seattle Genetics ” data-reactid=”29″> See our latest analysis for Seattle Genetics
Given that Seattle Genetics didn’t make a profit in the last twelve months, we’ll focus on revenue growth to form a quick view of its business development. When a company doesn’t make profits, we’d generally expect to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.
For the last half decade, Seattle Genetics can boast revenue growth at a rate of 24% per year. Even measured against other revenue-focussed companies, that’s a good result. Meanwhile, its share price performance certainly reflects the strong growth, given the share price grew at 30% per year, compound, during the period. So it seems likely that buyers have paid attention to the strong revenue growth. To our minds that makes Seattle Genetics worth investigating – it may have its best days ahead.
You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).
report showing consensus forecasts” data-reactid=”49″>Seattle Genetics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. So we recommend checking out this free report showing consensus forecasts
A Different Perspective
1 warning sign we’ve spotted with Seattle Genetics .” data-reactid=”51″>We’re pleased to report that Seattle Genetics shareholders have received a total shareholder return of 115% over one year. That’s better than the annualised return of 30% over half a decade, implying that the company is doing better recently. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 1 warning sign we’ve spotted with Seattle Genetics .
list of companies that have proven they can grow earnings.” data-reactid=”52″>If you would prefer to check out another company — one with potentially superior financials — then do not miss this free list of companies that have proven they can grow earnings.
Get in touch with us directly. Alternatively, email [email protected].” data-reactid=”54″>This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected].